Document is current
Any future updates will be listed below
-
Authors
Bergamini, Alice
Gargiulo, Piera
Iacovino, Maria Lucia https://orcid.org/0000-0001-9957-6170
Arenare, Laura https://orcid.org/0000-0001-7100-4517
Tuninetti, Valentina https://orcid.org/0000-0002-7377-0888
De Giorgi, Ugo
Savarese, Antonella
Di Bella, Sara
Mangili, Giorgia
Valabrega, Giorgio
Parretta, Mariangela
Cioffi, Raffaella https://orcid.org/0000-0003-4370-8271
Vasta, Francesca Maria
Evangelista, Giulia
Stefanelli, Pasquale
Piccirillo, Maria Carmela
Schettino, Clorinda
Maglietta, Giuseppe https://orcid.org/0000-0003-4497-1872
Iannelli, Elisabetta
Caminiti, Caterina
Maiello, Evaristo
Pinto, Carmine
Perrone, Francesco https://orcid.org/0000-0002-9738-0526
- License Information
-
More Information
Article History
Received: 3 June 2026
Accepted: 17 September 2026
First Online: 8 October 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Ethical Committee IRCCS Pascale on the 4th of July 2018 (Protocol number 16/18 OSS). All patients provided written informed consent to participate.
Competing interests: FP reports honoraria for consulting or advisory role from Viatris. MCP reports honoraria for speaker activities from AstraZeneca; advisory board participation for AstraZeneca; consultancy for Gilead; travel and meeting support from Menarini. UDG reports consulting or advisory roles for Pfizer, Janssen, Astellas Pharma, Bristol Myers Squibb, Bayer, Ipsen, MSD, PharmaMar, Novartis, Dompé Farmaceutici, Clovis Oncology, AstraZeneca, Eisai, Amgen, and Merck; research funding from Sanofi (institutional), AstraZeneca (institutional), and Roche (institutional); and travel, accommodation, and expenses support from Ipsen, Pfizer, AstraZeneca/Daiichi Sankyo, and Merck. CP reports honoraria for consulting or advisory roles from Daiichi Sankyo, AstraZeneca, Ipsen, Astellas, Bristol Myers Squibb, and Amgen; research funding from AstraZeneca, Bristol Myers Squibb, and GSK; and travel, accommodation, and expenses support from Merck, Servier, and Roche.All other authors declare no competing interests.
